Publications by authors named "Christine Desmedt"

100Publications

Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.

J Clin Oncol 2020 Sep 2;38(25):2883-2891. Epub 2020 Jul 2.

Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01771DOI Listing
September 2020

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer.

Breast 2020 Aug 8;52:64-70. Epub 2020 May 8.

Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumouri, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2020.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375586PMC
August 2020

MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer.

Cancers (Basel) 2020 Jan 16;12(1). Epub 2020 Jan 16.

Laboratory of Experimental and Translational Oncology, Pathology, Department of Oncology, Microbiology and Immunology, Faculty of Sciences and Medicine, University of Fribourg, 1700 Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12010223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016640PMC
January 2020

Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer.

Cancer Commun (Lond) 2019 06 19;39(1):35. Epub 2019 Jun 19.

Unit of Medical Statistics, Biometry and Bioinformatics, Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Laboratory of Medical Statistics and Epidemiology, "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan, Via Vanzetti 5, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40880-019-0381-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582468PMC
June 2019

Tumor dormancy at bedside: A late awakening.

Breast 2019 Jun 2;45:61-63. Epub 2019 Mar 2.

Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2019.03.001DOI Listing
June 2019

Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer.

J Natl Cancer Inst 2019 07;111(7):742-746

Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, U-CRC, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz023DOI Listing
July 2019

Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer.

Breast Cancer Res 2019 02 15;21(1):25. Epub 2019 Feb 15.

Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1111-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377756PMC
February 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

Oncogene 2019 04 13;38(15):2814-2829. Epub 2018 Dec 13.

Pathology Unit, Department of Oncology, Microbiology and Immunology (OMI), Faculty of Science and Medicine, University of Fribourg, 1700, Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0624-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477891PMC
April 2019

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.

BMC Cancer 2018 Jun 13;18(1):651. Epub 2018 Jun 13.

Laboratory of Medical Statistics and Epidemiology,"Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan, Via Vanzetti 5, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4558-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998599PMC
June 2018

Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.

J Natl Cancer Inst 2018 10;110(10):1115-1122

Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro," Department of Clinical Sciences and Community Health, University of Milan, Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy042DOI Listing
October 2018

Recurrence dynamics of breast cancer according to baseline body mass index.

Eur J Cancer 2017 12 31;87:10-20. Epub 2017 Oct 31.

Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.10.007DOI Listing
December 2017

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.

J Clin Invest 2017 Aug 17;127(8):3090-3102. Epub 2017 Jul 17.

Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI91095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531413PMC
August 2017

Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.

Clin Cancer Res 2017 Jun;23(11):2630-2639

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2548DOI Listing
June 2017

Transcriptomic and genomic features of invasive lobular breast cancer.

Semin Cancer Biol 2017 06 8;44:98-105. Epub 2017 Apr 8.

Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium; Department of Pathology/TCRU, Sint Augustinus, Wilrijk, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.03.007DOI Listing
June 2017

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Catalog of genetic progression of human cancers: breast cancer.

Cancer Metastasis Rev 2016 Mar;35(1):49-62

2nd Department of Pathology, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-016-9609-1DOI Listing
March 2016

Genomic Characterization of Primary Invasive Lobular Breast Cancer.

J Clin Oncol 2016 06 29;34(16):1872-81. Epub 2016 Feb 29.

Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.0334DOI Listing
June 2016

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

JAMA Oncol 2016 Feb;2(2):217-24

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4377DOI Listing
February 2016

CCR 20th Anniversary Commentary: Gene-Expression Signature in Breast Cancer--Where Did It Start and Where Are We Now?

Clin Cancer Res 2015 Nov;21(21):4743-6

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-3127DOI Listing
November 2015

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

J Clin Oncol 2015 May 20;33(15):1680-7. Epub 2015 Apr 20.

John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn, and Christopher J. Poole, University of Warwick, Coventry; Helena M. Earl and Carlos Caldas, University of Cambridge, Cambridge; Christopher J. Twelves, St James's University Hospital, Leeds; Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom; Christine Desmedt and Denis P. Larsimont, Université Libre de Bruxelles, Brussels, Belgium; Fatima Cardoso, Champalimaud Cancer Centre, Lisbon, Portugal; Maj-Britt Jensen and Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; and Angelo Di Leo, Hospital of Prato, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7869DOI Listing
May 2015

Informed consent, biobank research, and locality: perceptions of breast cancer patients in three European countries.

J Empir Res Hum Res Ethics 2014 Jul;9(3):48-55

Research Center for Biotechnology, Society and the Environment, University of Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1556264614540600DOI Listing
July 2014

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.

Science 2014 Aug;345(6196):1251343

Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1251343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380235PMC
August 2014

Evolving paradigms in multifocal breast cancer.

Semin Cancer Biol 2015 Apr 24;31:111-8. Epub 2014 Jul 24.

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2014.07.002DOI Listing
April 2015

Biology of breast cancer during pregnancy using genomic profiling.

Endocr Relat Cancer 2014 Aug 13;21(4):545-54. Epub 2014 May 13.

Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0111DOI Listing
August 2014

Impact of tumor sequencing on the use of anticancer drugs.

Curr Opin Oncol 2014 May;26(3):347-56

aThomas Conseil SPRL bBreast Cancer Translational Research Laboratory, Institut Jules Bordet cDepartment of Medicine, Medical Oncology Clinic, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000078DOI Listing
May 2014

Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment.

Analyst 2014 Mar;139(5):1044-56

Laboratory for the Structure and Function of Biological Membranes, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles (ULB), Bld du Triomphe 2, CP206/2, B1050 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3an01454aDOI Listing
March 2014

TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.

Future Oncol 2013 Oct;9(10):1477-87

'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.13.103DOI Listing
October 2013

Signatures of mutational processes in human cancer.

Nature 2013 Aug 14;500(7463):415-21. Epub 2013 Aug 14.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776390PMC
August 2013

Next-generation sequencing in breast cancer: first take home messages.

Curr Opin Oncol 2012 Nov;24(6):597-604

Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e328359554eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713550PMC
November 2012

Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Crit Rev Oncol Hematol 2012 Dec 7;84 Suppl 1:e58-69. Epub 2012 Sep 7.

Breast Cancer Translational Research Unit, Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.08.003DOI Listing
December 2012

A three-gene model to robustly identify breast cancer molecular subtypes.

J Natl Cancer Inst 2012 Feb 18;104(4):311-25. Epub 2012 Jan 18.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283537PMC
February 2012

Multiple-input multiple-output causal strategies for gene selection.

BMC Bioinformatics 2011 Nov 25;12:458. Epub 2011 Nov 25.

Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-12-458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323860PMC
November 2011

Gene profiling assay and application: the predictive role in primary therapy.

J Natl Cancer Inst Monogr 2011 ;2011(43):124-7

Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgr040DOI Listing
March 2012

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Endocr Relat Cancer 2011 Dec 14;18(6):721-30. Epub 2011 Nov 14.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-11-0180DOI Listing
December 2011

Time to move forward from "first-generation" prognostic gene signatures in early breast cancer.

Breast Cancer Res Treat 2011 Aug 16;128(3):643-5. Epub 2010 Oct 16.

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Bruxelles, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1213-4DOI Listing
August 2011

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.

Curr Opin Oncol 2010 Nov;22(6):547-51

Department of Medical Oncology, Institut Gustave Roussy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32833fb384DOI Listing
November 2010

Doubling back on centromere 17 in early breast cancer.

Lancet Oncol 2010 Mar;11(3):216-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70020-6DOI Listing
March 2010

A fuzzy gene expression-based computational approach improves breast cancer prognostication.

Genome Biol 2010 15;11(2):R18. Epub 2010 Feb 15.

Functional Genomics and Translational Research Unit, Medical Oncology Department, Jules Bordet Institute, Boulevard de Waterloo, Brussels, 1000, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gb-2010-11-2-r18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872878PMC
August 2010

Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

J Clin Oncol 2009 Jul 13;27(19):3185-91. Epub 2009 Apr 13.

DPhil, Departments of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.5934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716940PMC
July 2009

HER-2 as a target for breast cancer therapy.

Clin Cancer Res 2009 Mar;15(6):1848-52

Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1844DOI Listing
March 2009

Development and validation of gene expression profile signatures in early-stage breast cancer.

Cancer Invest 2009 Jan;27(1):1-10

Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900802574710DOI Listing
January 2009

Comparison of prognostic gene expression signatures for breast cancer.

BMC Genomics 2008 Aug 21;9:394. Epub 2008 Aug 21.

Functional Genomics Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-9-394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533026PMC
August 2008